BRIEF-Alkermes Plc starts Phase 1 clinical study of immuno-oncology drug candidate
May 25, 2016 at 07:35 AM EDT
* Initiation of phase 1 clinical study of immuno-oncology drug candidate ALKS 4230
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.